Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterations

Grégoire Cullot,Eric J. Aird,Moritz F. Schlapansky,Charles D. Yeh,Lilly van de Venn,Iryna Vykhlyantseva,Susanne Kreutzer,Dominic Mailänder,Bohdan Lewków,Julia Klermund,Christian Montellese,Martina Biserni,Florian Aeschimann,Cédric Vonarburg,Helmuth Gehart,Toni Cathomen,Jacob E. Corn
DOI: https://doi.org/10.1038/s41587-024-02488-6
IF: 46.9
2024-11-28
Nature Biotechnology
Abstract:The DNA-PKcs inhibitor AZD7648 enhances CRISPR–Cas9-directed homology-directed repair efficiencies, with potential for clinical utility, but its possible on-target consequences are unknown. We found that genome editing with AZD7648 causes frequent kilobase-scale and megabase-scale deletions, chromosome arm loss and translocations. These large-scale chromosomal alterations evade detection through typical genome editing assays, prompting caution in deploying AZD7648 and reinforcing the need to investigate multiple types of potential editing outcomes.
biotechnology & applied microbiology
What problem does this paper attempt to address?